AAOpt 2023: Rapid fire review of dry eye therapies

News
Video

A rapid fire session details what's in the pipeline for ocular surface dryness therapies.

At the 2023 American Academy of Optometry Meeting (AAOpt) meeting Mila Ioussifova, OD, FAAO, co-presented the session, "Sunny With a Chance of Tears: What's in the Forecast for Ocular Surface Dryness Therapies?" Doll presented alongside Tracy Doll, OD, FAAO; Lisa Hornick, OD, MBA, FAAO; and Pamela E. Theriot, OD, FAAO.

Video transcript

Editor's note: This transcript has been lightly edited for clarity.

Mila Ioussifova, OD, FAAO:
Hi, I'm Dr Mila Ioussifova. I am the optometrist and owner at South Waterfront Eye Care in Portland, Oregon.

Yes, it's a really exciting rapid fire lecture titled, "Sunny with a Chance of Tears, Forecast in Ocular Surface Dryness Therapies." So it's gonna be weather themed lectures. We're gonna have some props and have fun and discuss all the new technologies and all the advanced treatments in dry eye and what's coming also. It's a jam packed lecture. We have a lot of information, so we're not gonna get into too much detail of everything because there's so much to cover.

It's really exciting because we'll be able to touch on everything that's new in dry eye therapies, but also a little bit on how to implement it [and] how to use it in clinic. But again, it's going to be really quick. We're gonna be able to cover a lot in just under an hour.

The future of dry eyes [is] looking bright. We have a lot of new technologies and treatments in the pipelines and we have a lot [more] already great options for our patients now than we did 5, 10 years ago. It's an exciting time to actually treat patients with dry eye because a lot of these patients really need a lot of help. So, having the tools that we have now, this is the best time to actually treat dry eye because we have so many options for our patients.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, details the key takeaways from a poster presentation she participated in during ARVO 2025.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
© 2025 MJH Life Sciences

All rights reserved.